Home/Filings/4/0001789335-26-000002
4//SEC Filing

Chan Mitchell 4

Accession 0001789335-26-000002

CIK 0001590877other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:33 PM ET

Size

7.7 KB

Accession

0001789335-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-06
Chan Mitchell
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2026-01-06+73,749127,717 total
  • Award

    Stock Options (Right to buy)

    2026-01-06+39,65039,650 total
    Exercise: $14.18Exp: 2036-01-06Common Stock (39,650 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer.
  • [F2]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001789335

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:33 PM ET
Size
7.7 KB